Meet us at Tides Europe 2026, Stand No. 805, Nov 3-5, RAI Amsterdam, Netherlands Schedule a Meeting
Neuland supports peptide development programs with analytical development, validation, characterization, and stability studies designed to support process development, manufacturing, product release, and regulatory requirements.
Analytical development plays a critical role in advancing peptide programs from early development through commercialization. By generating reliable data on quality, purity, stability, and product performance, analytical studies help support process development, regulatory submissions, manufacturing readiness, and product release decisions throughout the program lifecycle
From Method Development to Product Release Confidence
Develop fit-for-purpose methods for identity, assay, impurities, and related substances.
Assess process-related impurities, degradation products, residual solvents, and potential impurity risks.
Confirm identity, structural features, and material attributes using suitable analytical techniques.
Partner with Neuland for analytical development, validation, characterization, and stability support across the peptide development lifecycle.
Quick answers to help you better understand our CDMO capabilities and approach.
Still Have Questions? Contact UsAnalytical development generates the data required to understand peptide quality throughout development and manufacturing. It helps establish identity, purity, impurity profiles, and stability characteristics while supporting process development, product release, regulatory submissions, and long-term supply.
Peptide characterization typically involves a combination of chromatographic, spectroscopic, and mass spectrometry-based techniques. These methods help evaluate peptide identity, purity, molecular weight, structural integrity, and impurity profiles throughout the product lifecycle.
Peptide impurities are identified using analytical methods designed to detect sequence-related impurities, degradation products, and process-related contaminants. Advanced chromatographic separation and mass spectrometry techniques help determine impurity identity, origin, and concentration.
Yes. Neuland develops, validates, and transfers analytical methods to support peptide programs from early development through commercial manufacturing. This helps ensure robust testing, regulatory compliance, and seamless transfer between development and quality control laboratories.
Neuland supports accelerated stability studies, long-term stability studies, forced degradation studies, and stability-indicating assessments. These studies help evaluate product behavior over time and generate data needed to establish appropriate storage conditions and shelf life.
Perform accelerated, long-term, and forced degradation studies.
Validate performance for parameters such as accuracy, precision, specificity, linearity, and robustness.
Transfer methods into QC and manufacturing environments for continuity.
Support release testing and ongoing quality control with reliable analytical methods.
